Benefit on Chronic Pain of Early Screening and Management of Patients With Persistent Postoperative Pain at 3 Months

NCT ID: NCT07160595

Last Updated: 2025-09-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

2052 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-30

Study Completion Date

2028-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic postoperative pain has an overall incidence of approximately 30%, with 5% to 10% of cases classified as severe (numerical rating scale \> 6/10). However, its management remains suboptimal, primarily due to underdiagnosis and delayed referral of patients to specialized chronic pain centers.

Improving the screening of patients with chronic postoperative pain is therefore crucial. Our research has shown that early detection of postoperative neuropathic pain is possible using just two text messages (SMS), as early as three months after surgery. Early screening, combined with prompt management, can prevent pain from becoming chronic and mitigate its harmful effects.

Study design

This study is a cluster crossover randomized trial. All participating centers (n=16) will take part in two sequential study periods:

* Control Period: "Without early treatment at 3 months" During this period, patients with persistent postoperative pain-identified via SMS-will receive treatment at 6 months. This reflects the current standard of care for patients with postoperative pain.
* Intervention Period: "With early treatment at 3 months" During this period, patients with persistent postoperative pain-identified via SMS-will receive early treatment starting at 3 months.

Study Population

The study will include patients undergoing the following minor surgical procedures:

* Inguinal hernia repair
* Breast reduction
* Mastectomy with lymph node dissection
* Knee arthroscopy
* Knee ligament reconstruction

Study Schedule Recruitment Period: 24 months Patient Follow-up: 6 months Total Estimated Study Duration: 30 months

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This study is a cluster crossover randomized trial. All participating centers (n=16) will take part in two sequential study periods:

* Control Period: "Without early treatment at 3 months" During this period, patients with persistent postoperative pain-identified via SMS-will receive treatment at 6 months. This reflects the current standard of care for patients with postoperative pain.
* Intervention Period: "With early treatment at 3 months" During this period, patients with persistent postoperative pain-identified via SMS-will receive early treatment starting at 3 months.

Each center will be randomized into one of two sequences: "control period followed by intervention period" or "intervention period followed by control period."
Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control period 'without early intervention at 3 months'

During this period, patients with persistent post-operative pain, identified through SMS screening, will be treated at 6 months (this reflects the current standard experience for patients with postoperative pain).

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention period 'with early intervention at 3 months'

During this period, patients with persistent post-operative pain, identified through SMS screening, will receive early treatment starting at 3 months.

Group Type EXPERIMENTAL

Early management of postoperative pain at 3 months detected using sms

Intervention Type OTHER

During this period, patients with persistent post-operative pain, identified through SMS screening, will receive early treatment starting at 3 months.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early management of postoperative pain at 3 months detected using sms

During this period, patients with persistent post-operative pain, identified through SMS screening, will receive early treatment starting at 3 months.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have undergone one of the following procedures:

* Inguinal hernia repair, regardless of the surgical technique used
* Breast reduction
* Mastectomy with or without reconstruction but with lymph node dissection
* Knee arthroscopy or knee ligamentoplasty

* Patients with a smartphone
* French-speaking patients
* Patients affiliated with a social security
* Patients who have given their free and informed verbal consent

Exclusion Criteria

* Patients with pain sensitivity defined by the presence of chronic pain, use of level 3 morphine analgesics, use of anxiolytics, gabapentinoids and/or antidepressants
* Patients subject to legal protection measures
* Patients deprived of their liberty
* Pregnant, labouring or breastfeeding patients
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation Hôpital Saint-Joseph

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Prive Claude Galien

Boussy-Saint-Antoine, , France

Site Status

Hospices Civils de Lyon

Lyon, , France

Site Status

Clinique Jules Verne

Nantes, , France

Site Status

Hôpital Privé du confluent Santé Atlantique

Nantes, , France

Site Status

AP-HP : Hôpital de la Pitié Salpêtrière

Paris, , France

Site Status

AP-HP : Hôpital Saint-Louis

Paris, , France

Site Status

Clinique Drouot Remusat

Paris, , France

Site Status

Clinique Geoffroy Saint Hilaire

Paris, , France

Site Status

Hôpital de la Croix Saint-Simon

Paris, , France

Site Status

Hôpital Paris Saint-Joseph

Paris, , France

Site Status

Institut Curie : Hôpital de Paris

Paris, , France

Site Status

Institut Mutualiste Montsouris

Paris, , France

Site Status

Institut Curie : Hôpital de Saint Cloud

Saint-Cloud, , France

Site Status

CHU de Saint-Etienne

Saint-Etienne, , France

Site Status

Hôpital Foch

Suresnes, , France

Site Status

CHU de Toulouse

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Frédéric ADAM, Doctor of Medicine

Role: CONTACT

01 44 12 36 18

Célia MAMMA

Role: CONTACT

01 44 12 32 54

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Célia MAMMA

Role: primary

01 44 12 32 54

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ID RCB

Identifier Type: OTHER

Identifier Source: secondary_id

731_DROPS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PREventing Pain After Surgery
NCT05306665 RECRUITING NA
Transition From Acute to Chronic Opioid Use and Chronic Pain
NCT07211399 NOT_YET_RECRUITING EARLY_PHASE1